Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 trial assessing safety, tolerability, PK/PD, and efficacy of repeat dosing of GSK2982772 in moderate to severe rheumatoid arthritis;…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) [Phase 4]
Phase 4 trial update on etanercept and methotrexate in early arthritis aiming to induce remission.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA) [Phase 4]
Phase 4 trial update for infliximab as induction therapy in early rheumatoid arthritis has completed enrollment and study completion status.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Targeted Ultrasound in Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial update on targeted ultrasound as a monitoring/assessment tool for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial comparing etoricoxib with aceclofenac in patients with rheumatoid arthritis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update evaluating a self-injection e-device for certolizumab pegol in several inflammatory diseases; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to Rituximab [Phase 3]
Phase 3 clinical trial evaluating ABP 798 versus rituximab in moderate to severe rheumatoid arthritis has completed with posted results in 2…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX
A completed clinical trial comparing outcomes of rheumatoid arthritis patients starting Xeljanz with oral methotrexate who withdraw MTX vers…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis [Phase 1, Phase 2]
Clinical trial update for BMS-986251 (oral) in healthy participants and patients with psoriasis and rheumatoid arthritis; study terminated w…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs [Phase 2, Phase 3]
A clinical trial comparing upadacitinib to placebo in adults with rheumatoid arthritis who are on csDMARDs and have inadequate response to c…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: A Study of LY3337641 in Rheumatoid Arthritis [Phase 2]
Phase 2 study of LY3337641 in rheumatoid arthritis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: TOLERA: Tolerance Enhancement in RA [Phase 2]
Phase 2 clinical trial update for TOLERA aiming at tolerance enhancement in rheumatoid arthritis; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate [Phase 3]
Phase 3 trial comparing Upadacitinib (ABT-494) to placebo and to adalimumab in adults with rheumatoid arthritis inadequately responsive to m…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY) [Phase 3]
Phase 3 trial comparing upadacitinib monotherapy to methotrexate in adults with rheumatoid arthritis inadequately responding to MTX, complet…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone [Phase 3]
Phase 3 trial comparing upadacitinib to placebo in adults with rheumatoid arthritis on csDMARDs who had an inadequate response, results post…
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs [Phase 3]
Phase 3 trial comparing upadacitinib to placebo in adults with rheumatoid arthritis who had an inadequate response or intolerance to biologi…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate [Phase 3]
Phase 3 trial comparing upadacitinib monotherapy to methotrexate monotherapy in adults with rheumatoid arthritis; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone [Phase 2]
Phase 2 trial assessing the efficacy and safety of upadacitinib with methotrexate in adults with rheumatoid arthritis who had an inadequate …
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial comparing combination disease-modifying antirheumatic drugs with methotrexate therapy in early rheumatoid arthritis…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis [Phase 1]
A Phase 1b study of MEDI4920 in adults with rheumatoid arthritis has completed, and the results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
A completed real-world outcome study evaluating adalimumab in Chinese patients with rheumatoid arthritis, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) [Phase 2]
Phase 2 trial evaluating GDC-0853 versus placebo and adalimumab in rheumatoid arthritis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis [Phase 2]
Phase 2 trial updates the evaluation of low-dose recombinant human IL-2 for rheumatoid arthritis, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Very Early Versus Delayed Etanercept in Patients With RA [Phase 4]
Phase 4 trial comparing very early versus delayed initiation of etanercept in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab [Phase 3]
Phase 3 trial comparing ABP710 to infliximab in moderate to severe rheumatoid arthritis has completed with posted results.